July 24, 2007


A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
              +1 (978) 421-9655         +1 (978) 421-9655


Diane Egan
ZOLL Medical Corporation
              +1 (978) 421-9637         +1 (978) 421-9637

ZOLL Medical Wins Sixth Straight Omega NorthFace Scoreboard Award for Customer Service Excellence in Technical Support

July 23, 2007—CHELMSFORD, MASS.—ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that it has won the Omega NorthFace ScoreBoard AwardSM for a sixth consecutive year. The award is presented annually by the Omega Management Group Corp., Billerica, Mass., a leader in implementing customer satisfaction and retention programs.

“Since 2000, ZOLL’s customer satisfaction levels for technical support and customer service/delivery process have consistently remained high,” said Richard A. Packer, President and Chief Executive Officer of ZOLL. “This type of consistency year after year clearly demonstrates the importance we place on customer service as we develop products that help advance the practice of resuscitation.”

The Omega NorthFace ScoreBoard Award is presented to organizations that not only offer exemplary service to their customers, but also center their existence on a deep commitment to exceed all customer expectations.

To qualify for the NorthFace ScoreBoard Award, a company must meet four criteria:

1. Senior management commitment to exceeding customer expectations;

2. Customer satisfaction program that identifies and corrects customer problems;

3. Measuring the level of customer satisfaction with product/service; and

4. Achieving an overall score of 4.0 out of 5.0 for a year.

In ZOLL’s case, Omega (www.omegascoreboard.com) conducted quarterly telephone surveys with 100 customers to determine levels of achievement and quantify results.

About ZOLL Medical Corporation

ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.

ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.

Certain statements contained in this press release regarding matters that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, ZOLL’s ability to compete in the resuscitation business; acceptance of its recently launched products; changes in regulations affecting the healthcare industry; global economic conditions; and those other factors discussed in the section entitled “Risk Factors” in ZOLL’s Quarterly Report on Form 10-Q, which was filed with the SEC on May 11, 2007.

©2007 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105.

NorthFace ScoreBoard Award is a service mark of Omega Management Group Corp.